医療用ヒアルロン酸(HA)のグローバル市場展望 2023年-2029年:注射、パッチ

■ 英語タイトル:Hyaluronic Acid (HA) for Medical Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート(データ管理コード:MMG23LY8784)■ 発行会社/調査会社:Market Monitor Global
■ 商品コード:MMG23LY8784
■ 発行日:2023年7月
■ 調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野:医薬品&ヘルスケア
■ ページ数:71
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後2-3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[医療用ヒアルロン酸(HA)のグローバル市場展望 2023年-2029年:注射、パッチ]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

当調査レポートは次の情報を含め、世界の医療用ヒアルロン酸(HA)市場規模と予測を収録しています。・世界の医療用ヒアルロン酸(HA)市場:売上、2018年-2023年、2024年-2029年
・世界の医療用ヒアルロン酸(HA)市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の医療用ヒアルロン酸(HA)市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「注射」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

医療用ヒアルロン酸(HA)のグローバル主要企業は、Kewpie、 CPN、 Shiseido、 Novozymes、 Bloomage BioTechnology、 Shandong Galaxy Bio-Tech、 China Eastar、 FocusChem Biotech、 Shandong Topscience Biotech、 QuFu GuangLong Biochem、 Weifang Lide Bioengineering、 Jiangsu Haihua Biotech、 Qufu Liyang Biochem Industrial、 HAOHAI BIO-MEDなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、医療用ヒアルロン酸(HA)のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の医療用ヒアルロン酸(HA)市場:タイプ別、2018年-2023年、2024年-2029年
世界の医療用ヒアルロン酸(HA)市場:タイプ別市場シェア、2022年
・注射、パッチ

世界の医療用ヒアルロン酸(HA)市場:用途別、2018年-2023年、2024年-2029年
世界の医療用ヒアルロン酸(HA)市場:用途別市場シェア、2022年
・医療衛生、形成外科、健康食品、その他

世界の医療用ヒアルロン酸(HA)市場:地域・国別、2018年-2023年、2024年-2029年
世界の医療用ヒアルロン酸(HA)市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における医療用ヒアルロン酸(HA)のグローバル売上、2018年-2023年
・主要企業における医療用ヒアルロン酸(HA)のグローバル売上シェア、2022年
・主要企業における医療用ヒアルロン酸(HA)のグローバル販売量、2018年-2023年
・主要企業における医療用ヒアルロン酸(HA)のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Kewpie、 CPN、 Shiseido、 Novozymes、 Bloomage BioTechnology、 Shandong Galaxy Bio-Tech、 China Eastar、 FocusChem Biotech、 Shandong Topscience Biotech、 QuFu GuangLong Biochem、 Weifang Lide Bioengineering、 Jiangsu Haihua Biotech、 Qufu Liyang Biochem Industrial、 HAOHAI BIO-MED

*************************************************************

・調査・分析レポートの概要
医療用ヒアルロン酸(HA)市場の定義
市場セグメント
世界の医療用ヒアルロン酸(HA)市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の医療用ヒアルロン酸(HA)市場規模
世界の医療用ヒアルロン酸(HA)市場規模:2022年 VS 2029年
世界の医療用ヒアルロン酸(HA)市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの医療用ヒアルロン酸(HA)の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の医療用ヒアルロン酸(HA)製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:注射、パッチ
医療用ヒアルロン酸(HA)のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:医療衛生、形成外科、健康食品、その他
医療用ヒアルロン酸(HA)の用途別グローバル売上・予測

・地域別市場分析
地域別医療用ヒアルロン酸(HA)市場規模 2022年と2029年
地域別医療用ヒアルロン酸(HA)売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Kewpie、 CPN、 Shiseido、 Novozymes、 Bloomage BioTechnology、 Shandong Galaxy Bio-Tech、 China Eastar、 FocusChem Biotech、 Shandong Topscience Biotech、 QuFu GuangLong Biochem、 Weifang Lide Bioengineering、 Jiangsu Haihua Biotech、 Qufu Liyang Biochem Industrial、 HAOHAI BIO-MED
...

Hyaluronic acid also called hyaluronan, is an anionic, nonsulfated glycosaminoglycan. HA and its derivatives have been clinically used as medical products for over three decades
This report aims to provide a comprehensive presentation of the global market for Hyaluronic Acid (HA) for Medical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyaluronic Acid (HA) for Medical. This report contains market size and forecasts of Hyaluronic Acid (HA) for Medical in global, including the following market information:
Global Hyaluronic Acid (HA) for Medical Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hyaluronic Acid (HA) for Medical Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Hyaluronic Acid (HA) for Medical companies in 2022 (%)
The global Hyaluronic Acid (HA) for Medical market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hyaluronic Acid (HA) for Medical include Kewpie, CPN, Shiseido, Novozymes, Bloomage BioTechnology, Shandong Galaxy Bio-Tech, China Eastar, FocusChem Biotech and Shandong Topscience Biotech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hyaluronic Acid (HA) for Medical manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hyaluronic Acid (HA) for Medical Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hyaluronic Acid (HA) for Medical Market Segment Percentages, by Type, 2022 (%)
Injection
Patch
Global Hyaluronic Acid (HA) for Medical Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hyaluronic Acid (HA) for Medical Market Segment Percentages, by Application, 2022 (%)
Medical Hygiene
Plastic Surgery
Health Products
Other
Global Hyaluronic Acid (HA) for Medical Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hyaluronic Acid (HA) for Medical Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hyaluronic Acid (HA) for Medical revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hyaluronic Acid (HA) for Medical revenues share in global market, 2022 (%)
Key companies Hyaluronic Acid (HA) for Medical sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hyaluronic Acid (HA) for Medical sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Kewpie
CPN
Shiseido
Novozymes
Bloomage BioTechnology
Shandong Galaxy Bio-Tech
China Eastar
FocusChem Biotech
Shandong Topscience Biotech
QuFu GuangLong Biochem
Weifang Lide Bioengineering
Jiangsu Haihua Biotech
Qufu Liyang Biochem Industrial
HAOHAI BIO-MED
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hyaluronic Acid (HA) for Medical, market overview.
Chapter 2: Global Hyaluronic Acid (HA) for Medical market size in revenue and volume.
Chapter 3: Detailed analysis of Hyaluronic Acid (HA) for Medical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hyaluronic Acid (HA) for Medical in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hyaluronic Acid (HA) for Medical capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次(コンテンツ)***

1 Introduction to Research & Analysis Reports
1.1 Hyaluronic Acid (HA) for Medical Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hyaluronic Acid (HA) for Medical Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hyaluronic Acid (HA) for Medical Overall Market Size
2.1 Global Hyaluronic Acid (HA) for Medical Market Size: 2022 VS 2029
2.2 Global Hyaluronic Acid (HA) for Medical Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hyaluronic Acid (HA) for Medical Sales: 2018-2029
3 Company Landscape
3.1 Top Hyaluronic Acid (HA) for Medical Players in Global Market
3.2 Top Global Hyaluronic Acid (HA) for Medical Companies Ranked by Revenue
3.3 Global Hyaluronic Acid (HA) for Medical Revenue by Companies
3.4 Global Hyaluronic Acid (HA) for Medical Sales by Companies
3.5 Global Hyaluronic Acid (HA) for Medical Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hyaluronic Acid (HA) for Medical Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hyaluronic Acid (HA) for Medical Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hyaluronic Acid (HA) for Medical Players in Global Market
3.8.1 List of Global Tier 1 Hyaluronic Acid (HA) for Medical Companies
3.8.2 List of Global Tier 2 and Tier 3 Hyaluronic Acid (HA) for Medical Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Hyaluronic Acid (HA) for Medical Market Size Markets, 2022 & 2029
4.1.2 Injection
4.1.3 Patch
4.2 By Type – Global Hyaluronic Acid (HA) for Medical Revenue & Forecasts
4.2.1 By Type – Global Hyaluronic Acid (HA) for Medical Revenue, 2018-2023
4.2.2 By Type – Global Hyaluronic Acid (HA) for Medical Revenue, 2024-2029
4.2.3 By Type – Global Hyaluronic Acid (HA) for Medical Revenue Market Share, 2018-2029
4.3 By Type – Global Hyaluronic Acid (HA) for Medical Sales & Forecasts
4.3.1 By Type – Global Hyaluronic Acid (HA) for Medical Sales, 2018-2023
4.3.2 By Type – Global Hyaluronic Acid (HA) for Medical Sales, 2024-2029
4.3.3 By Type – Global Hyaluronic Acid (HA) for Medical Sales Market Share, 2018-2029
4.4 By Type – Global Hyaluronic Acid (HA) for Medical Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hyaluronic Acid (HA) for Medical Market Size, 2022 & 2029
5.1.2 Medical Hygiene
5.1.3 Plastic Surgery
5.1.4 Health Products
5.1.5 Other
5.2 By Application – Global Hyaluronic Acid (HA) for Medical Revenue & Forecasts
5.2.1 By Application – Global Hyaluronic Acid (HA) for Medical Revenue, 2018-2023
5.2.2 By Application – Global Hyaluronic Acid (HA) for Medical Revenue, 2024-2029
5.2.3 By Application – Global Hyaluronic Acid (HA) for Medical Revenue Market Share, 2018-2029
5.3 By Application – Global Hyaluronic Acid (HA) for Medical Sales & Forecasts
5.3.1 By Application – Global Hyaluronic Acid (HA) for Medical Sales, 2018-2023
5.3.2 By Application – Global Hyaluronic Acid (HA) for Medical Sales, 2024-2029
5.3.3 By Application – Global Hyaluronic Acid (HA) for Medical Sales Market Share, 2018-2029
5.4 By Application – Global Hyaluronic Acid (HA) for Medical Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Hyaluronic Acid (HA) for Medical Market Size, 2022 & 2029
6.2 By Region – Global Hyaluronic Acid (HA) for Medical Revenue & Forecasts
6.2.1 By Region – Global Hyaluronic Acid (HA) for Medical Revenue, 2018-2023
6.2.2 By Region – Global Hyaluronic Acid (HA) for Medical Revenue, 2024-2029
6.2.3 By Region – Global Hyaluronic Acid (HA) for Medical Revenue Market Share, 2018-2029
6.3 By Region – Global Hyaluronic Acid (HA) for Medical Sales & Forecasts
6.3.1 By Region – Global Hyaluronic Acid (HA) for Medical Sales, 2018-2023
6.3.2 By Region – Global Hyaluronic Acid (HA) for Medical Sales, 2024-2029
6.3.3 By Region – Global Hyaluronic Acid (HA) for Medical Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Hyaluronic Acid (HA) for Medical Revenue, 2018-2029
6.4.2 By Country – North America Hyaluronic Acid (HA) for Medical Sales, 2018-2029
6.4.3 US Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.4.4 Canada Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.4.5 Mexico Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Hyaluronic Acid (HA) for Medical Revenue, 2018-2029
6.5.2 By Country – Europe Hyaluronic Acid (HA) for Medical Sales, 2018-2029
6.5.3 Germany Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.5.4 France Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.5.5 U.K. Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.5.6 Italy Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.5.7 Russia Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.5.8 Nordic Countries Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.5.9 Benelux Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Hyaluronic Acid (HA) for Medical Revenue, 2018-2029
6.6.2 By Region – Asia Hyaluronic Acid (HA) for Medical Sales, 2018-2029
6.6.3 China Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.6.4 Japan Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.6.5 South Korea Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.6.6 Southeast Asia Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.6.7 India Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Hyaluronic Acid (HA) for Medical Revenue, 2018-2029
6.7.2 By Country – South America Hyaluronic Acid (HA) for Medical Sales, 2018-2029
6.7.3 Brazil Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.7.4 Argentina Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Hyaluronic Acid (HA) for Medical Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Hyaluronic Acid (HA) for Medical Sales, 2018-2029
6.8.3 Turkey Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.8.4 Israel Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.8.5 Saudi Arabia Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
6.8.6 UAE Hyaluronic Acid (HA) for Medical Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Kewpie
7.1.1 Kewpie Company Summary
7.1.2 Kewpie Business Overview
7.1.3 Kewpie Hyaluronic Acid (HA) for Medical Major Product Offerings
7.1.4 Kewpie Hyaluronic Acid (HA) for Medical Sales and Revenue in Global (2018-2023)
7.1.5 Kewpie Key News & Latest Developments
7.2 CPN
7.2.1 CPN Company Summary
7.2.2 CPN Business Overview
7.2.3 CPN Hyaluronic Acid (HA) for Medical Major Product Offerings
7.2.4 CPN Hyaluronic Acid (HA) for Medical Sales and Revenue in Global (2018-2023)
7.2.5 CPN Key News & Latest Developments
7.3 Shiseido
7.3.1 Shiseido Company Summary
7.3.2 Shiseido Business Overview
7.3.3 Shiseido Hyaluronic Acid (HA) for Medical Major Product Offerings
7.3.4 Shiseido Hyaluronic Acid (HA) for Medical Sales and Revenue in Global (2018-2023)
7.3.5 Shiseido Key News & Latest Developments
7.4 Novozymes
7.4.1 Novozymes Company Summary
7.4.2 Novozymes Business Overview
7.4.3 Novozymes Hyaluronic Acid (HA) for Medical Major Product Offerings
7.4.4 Novozymes Hyaluronic Acid (HA) for Medical Sales and Revenue in Global (2018-2023)
7.4.5 Novozymes Key News & Latest Developments
7.5 Bloomage BioTechnology
7.5.1 Bloomage BioTechnology Company Summary
7.5.2 Bloomage BioTechnology Business Overview
7.5.3 Bloomage BioTechnology Hyaluronic Acid (HA) for Medical Major Product Offerings
7.5.4 Bloomage BioTechnology Hyaluronic Acid (HA) for Medical Sales and Revenue in Global (2018-2023)
7.5.5 Bloomage BioTechnology Key News & Latest Developments
7.6 Shandong Galaxy Bio-Tech
7.6.1 Shandong Galaxy Bio-Tech Company Summary
7.6.2 Shandong Galaxy Bio-Tech Business Overview
7.6.3 Shandong Galaxy Bio-Tech Hyaluronic Acid (HA) for Medical Major Product Offerings
7.6.4 Shandong Galaxy Bio-Tech Hyaluronic Acid (HA) for Medical Sales and Revenue in Global (2018-2023)
7.6.5 Shandong Galaxy Bio-Tech Key News & Latest Developments
7.7 China Eastar
7.7.1 China Eastar Company Summary
7.7.2 China Eastar Business Overview
7.7.3 China Eastar Hyaluronic Acid (HA) for Medical Major Product Offerings
7.7.4 China Eastar Hyaluronic Acid (HA) for Medical Sales and Revenue in Global (2018-2023)
7.7.5 China Eastar Key News & Latest Developments
7.8 FocusChem Biotech
7.8.1 FocusChem Biotech Company Summary
7.8.2 FocusChem Biotech Business Overview
7.8.3 FocusChem Biotech Hyaluronic Acid (HA) for Medical Major Product Offerings
7.8.4 FocusChem Biotech Hyaluronic Acid (HA) for Medical Sales and Revenue in Global (2018-2023)
7.8.5 FocusChem Biotech Key News & Latest Developments
7.9 Shandong Topscience Biotech
7.9.1 Shandong Topscience Biotech Company Summary
7.9.2 Shandong Topscience Biotech Business Overview
7.9.3 Shandong Topscience Biotech Hyaluronic Acid (HA) for Medical Major Product Offerings
7.9.4 Shandong Topscience Biotech Hyaluronic Acid (HA) for Medical Sales and Revenue in Global (2018-2023)
7.9.5 Shandong Topscience Biotech Key News & Latest Developments
7.10 QuFu GuangLong Biochem
7.10.1 QuFu GuangLong Biochem Company Summary
7.10.2 QuFu GuangLong Biochem Business Overview
7.10.3 QuFu GuangLong Biochem Hyaluronic Acid (HA) for Medical Major Product Offerings
7.10.4 QuFu GuangLong Biochem Hyaluronic Acid (HA) for Medical Sales and Revenue in Global (2018-2023)
7.10.5 QuFu GuangLong Biochem Key News & Latest Developments
7.11 Weifang Lide Bioengineering
7.11.1 Weifang Lide Bioengineering Company Summary
7.11.2 Weifang Lide Bioengineering Hyaluronic Acid (HA) for Medical Business Overview
7.11.3 Weifang Lide Bioengineering Hyaluronic Acid (HA) for Medical Major Product Offerings
7.11.4 Weifang Lide Bioengineering Hyaluronic Acid (HA) for Medical Sales and Revenue in Global (2018-2023)
7.11.5 Weifang Lide Bioengineering Key News & Latest Developments
7.12 Jiangsu Haihua Biotech
7.12.1 Jiangsu Haihua Biotech Company Summary
7.12.2 Jiangsu Haihua Biotech Hyaluronic Acid (HA) for Medical Business Overview
7.12.3 Jiangsu Haihua Biotech Hyaluronic Acid (HA) for Medical Major Product Offerings
7.12.4 Jiangsu Haihua Biotech Hyaluronic Acid (HA) for Medical Sales and Revenue in Global (2018-2023)
7.12.5 Jiangsu Haihua Biotech Key News & Latest Developments
7.13 Qufu Liyang Biochem Industrial
7.13.1 Qufu Liyang Biochem Industrial Company Summary
7.13.2 Qufu Liyang Biochem Industrial Hyaluronic Acid (HA) for Medical Business Overview
7.13.3 Qufu Liyang Biochem Industrial Hyaluronic Acid (HA) for Medical Major Product Offerings
7.13.4 Qufu Liyang Biochem Industrial Hyaluronic Acid (HA) for Medical Sales and Revenue in Global (2018-2023)
7.13.5 Qufu Liyang Biochem Industrial Key News & Latest Developments
7.14 HAOHAI BIO-MED
7.14.1 HAOHAI BIO-MED Company Summary
7.14.2 HAOHAI BIO-MED Business Overview
7.14.3 HAOHAI BIO-MED Hyaluronic Acid (HA) for Medical Major Product Offerings
7.14.4 HAOHAI BIO-MED Hyaluronic Acid (HA) for Medical Sales and Revenue in Global (2018-2023)
7.14.5 HAOHAI BIO-MED Key News & Latest Developments
8 Global Hyaluronic Acid (HA) for Medical Production Capacity, Analysis
8.1 Global Hyaluronic Acid (HA) for Medical Production Capacity, 2018-2029
8.2 Hyaluronic Acid (HA) for Medical Production Capacity of Key Manufacturers in Global Market
8.3 Global Hyaluronic Acid (HA) for Medical Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hyaluronic Acid (HA) for Medical Supply Chain Analysis
10.1 Hyaluronic Acid (HA) for Medical Industry Value Chain
10.2 Hyaluronic Acid (HA) for Medical Upstream Market
10.3 Hyaluronic Acid (HA) for Medical Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hyaluronic Acid (HA) for Medical Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(MMG23LY8784 )"医療用ヒアルロン酸(HA)のグローバル市場展望 2023年-2029年:注射、パッチ" (英文:Hyaluronic Acid (HA) for Medical Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。